Global IVD Regulatory Affairs Outsourcing Market - Industry Trends and Forecast to 2029

Global IVD regulatory affairs outsourcing market is projected to register a CAGR of 13.3% in the forecast period of 2022 to 2029. The new market report contains data for historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029.

Market Segmentation:

Global IVD regulatory affairs outsourcing market, By services (regulatory writing & submissions, regulatory registration & clinical trial applications, regulatory consulting, legal representation, data management services, chemistry manufacturing and controls (CMC) services, and others), By indication (oncology, neurology, cardiology, clinical chemistry and immunoassays, precision medicine, infectious diseases, diabetes, genetic testing, HIV/AIDS, haematology, drug testing/pharmacogenomics, blood transfusion, point of care, and others), By deployment mode (cloud and on-premises), By organization size (small and medium enterprises (SMES) and large enterprises), By stage (clinical, preclinical, and PMA (post-market authorization)), By class (class I, class II, and class III), By end user (pharmaceutical companies, medical device companies, biotechnology companies, and others), Country (U.S., Canada, Mexico, U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Belgium, Turkey, and Rest of Europe, China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines and Rest of Asia-Pacific, South Africa, Saudi Arabia, U.A.E., Israel, Egypt, and Rest of Middle East and Africa, Brazil, Argentina, Colombia, Peru, Chile, Venezuela, Ecuador and rest of South America) Industry Trends and Forecast to 2029

Some of the major factors contributing to the growth of the Global IVD regulatory affairs outsourcing market are:

• Rise in prevalence of chronic diseases across the region is expected to drive the growth of the market

• Technological advancements in various in vitro diagnostic devices is also expected to accelerate the growth

Market Players

Some of the major players operating in the IVD regulatory affairs outsourcing market are:

• Freyr Solutions
• AXSource
• LORENZ Life Sciences Group
• PPD Inc. (A Subsidiary of Thermofisher Scientific Inc.)
• Promedica International
• Assent Compliance Inc.
• MakroCare
• EMERGO
• ICON
• Parexel International Corporation
• CRITERIUM, INC.
• Groupe ProductLife S.A
• Propharma Group
• VCLS
• Labcorp Drug Development
• WuXi AppTec
• Charles River Laboratories
• Genpact
• Medpace
• Andaman Medical
• Asia Actual
• Regulatory Compliance Associates Inc.
• RQM+
• Saraca Solutions Private Limited
• PBC BioMed
• Dor Pharmaceutical Services
• Qserve
• MARACA International BVBA
• mdiConsultants, Inc.